This study could help identify aggravating or protective genetic polymorphisms associated with cerebral palsy. Populations of premature babies at different risk of cerebral palsy could thus be individualized with an impact on their monitoring and on the pathophysiological understanding of the processes leading to neurological lesions.
Study Type
OBSERVATIONAL
Enrollment
27
no intervention
CHU Nantes
Nantes, France
Identify a polymorphism associated with the risk of developing cerebral palsy at 2 years in a regional population of premature infants of gestational age <34 weeks gestation.
frequency of variants within the case and control groups using the statistical criterion "level of significance" (also called p-value and known by the English word "p-value") of 5.10-8
Time frame: 2 years
Identify a specific polymorphism of certain forms of cerebral palsy
neurological examination
Time frame: 2 years
Develop a prognosis algorithm for the occurrence of cerebral palsy for personalized monitoring in a population at risk.
neurological examination
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.